Pharmacological properties pharmacodynamics. Synthetic levothyroxine, which is contained in the preparation L-Thyroxine 50 and 100 Berlin-Chemie, is identical in biological activity to the natural thyroid hormone. After partial conversion to liothyronine (T 3 ), usually in the liver and kidneys, and passing into the cells of the body, it affects the development, growth and metabolism. Pharmacokinetics. Absorption of oral levothyroxine […]

L-THIROXINE 100 BERLIN-CHEMIE, Berlin-Chemie AG Read More »

L-Thyroxine 100 Berlin-Chemie

  Levothyroxine sodium* (Levothyroxine sodium*) ATH H03AA01 Levothyroxine sodium Pharmacological group   Synthetic thyroid hormone [Thyroid hormones, analogues and antagonists (including antithyroid drugs)]   Composition and form of release   L-thyroxine 50 Berlin-Chemie Tablets 1 table levothyroxine sodium 50 mcg excipients: calcium hydrogen phosphate, water; MCC; carboxymethyl starch sodium salt (type A); dextrin; long chain partial glycerides   in a

L-Thyroxine 100 Berlin-Chemie Read More »


Active substance Levothyroxine sodium* (Levothyroxine sodium*) ATH H03AA01 Levothyroxine sodium Pharmacological group   Thyroid hormones, their analogs and antagonists (including antithyroid drugs)   Indications Hypothyroid states of various etiologies (including those caused by surgical or drug exposure), prevention of recurrence of nodular goiter after thyroid resection, diffuse euthyroid goiter; diffuse toxic goiter – after the creation

L-thyroxine Read More »


Asparaginase (Asparaginase) ATH L01XX02 Asparaginase Pharmacological group   Anticancer agent, enzyme [Other anticancer agents]   Composition   Lyophilizate for solution preparation for intravenous and intramuscular administration 1 dosage active substance: asparaginase 10000 ED excipients: mannitol – 80 mg   Description of the dosage form   White lyophilized mass. pharmachologic effect Pharmacological effect – antitumor. Pharmacodynamics  

L-Asparaginase Read More »

L-Lysine Aescinat (L-lysine aescinat)

Name:L-lysine aescinate (L-Lysine Aescinat) Indications for use: Post-traumatic, intra- and postoperative swelling of any localization: severe swelling of the brain and spinal cord, including subarachnoid and intracranial hematomas and displacement of the midline structures of the brain and edema-swelling syndrome; swelling of soft tissues involving the musculoskeletal system, accompanied by local disorders of their blood supply

L-Lysine Aescinat (L-lysine aescinat) Read More »